Drug Profile
Research programme: dimer therapeutics - OrphoMed
Alternative Names: ORP-102; ORP-103; ORP-105Latest Information Update: 28 Feb 2022
Price :
$50
*
At a glance
- Originator OrphoMed
- Class Non-opioid analgesics
- Mechanism of Action 5-HT1 serotonin receptor modulators; Adrenergic receptor modulators; Opioid mu receptor antagonists; Prostaglandin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Gastrointestinal disorders; Gastroparesis; Pain
Most Recent Events
- 28 Feb 2022 No recent reports of development identified for preclinical development in Gastrointestinal-disorders in USA
- 28 Feb 2022 No recent reports of development identified for preclinical development in Gastroparesis in USA
- 28 Feb 2022 No recent reports of development identified for preclinical development in Pain in USA